| Fecal Calprotectin Levels in Post-Metabolic Bariatric Surgery Patients: A Retrospective Study. Beeren, Fenna M M (FMM);Roosenboom, Britt (B);Spanier, Marcel B W (MBW);Groenen, Marcel J M (MJM);Siersema, Peter D (PD); |
|
Author information Inflamm Intest Dis.2025 Sep 29;10(1):329-336.doi:10.1159/000548160 Abstract INTRODUCTION: Fecal calprotectin (FCP) is a key biomarker for gastrointestinal inflammation, aiding in differentiating irritable bowel syndrome from active inflammatory bowel disease (IBD). Metabolic bariatric surgeries (MBSs), such as Roux-en-Y gastric bypass or sleeve gastrectomy, alter gastrointestinal physiology, potentially affecting the applicability of standard FCP cutoff values in this population. |
© Copyright 2013-2026 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.